WebSep 11, 2024 · Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2024: a pooled analysis of 1201 population-representative studies with 104 million participants Lancet. 2024 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. ... WebJun 15, 2024 · Hypertension is one of the leading causes of death globally each year, accounting for up to 30% of myocardial infarctions. Although the prevalence of …
Heart Disease and Stroke Statistics - 2024 Update
WebFeb 5, 2024 · Estimates suggest that 31.1% of adults (1.39 billion) worldwide had hypertension in 2010. The prevalence of hypertension among adults was higher in LMICs … WebAug 9, 2016 · Introduction. Editorial, see p 451. Hypertension is an important global health challenge because of its high prevalence and resulting cardiovascular disease and chronic kidney disease. 1 – 3 Hypertension is the leading preventable risk factor for premature death and disability worldwide. 3 Previous work estimated that 26.4% of the global adult … dane county drug court
Epidemiological trends of maternal hypertensive disorders of ... - PubMed
WebSep 25, 2024 · By 2010, the global burden of hypertension was estimated at approximately 1.4 billion, and is likely to substantially exceed 1.6 billion by 2025 [2]. In 2016, noncommunicable diseases accounted for 40.5 million or 71% of deaths globally; 17.9 million or 44% of noncommunicable disease-related deaths were due to cardiovascular … Web• CVD is the leading global cause of death, and accounted for approximately 18.6 million deaths in 2024. • CVD and stroke accounted for 13% of total health expenditures in 2014 to 2015. This is more than any major diagnostic group. Unlessotherwise noted, all statistics in this documentpertainto the United States. ©2024American ... WebMar 12, 2015 · The prevalence of hypertension was higher for men than for women and for older participants. The annual incidence rate in this population was around 8% to 9% for the first 4 years of follow-up and 5% to 6% for the next 5 years of follow-up in men and women aged 45 to 83 years at baseline. birmingham evening mail online